N.M. Stat. § 30-31-16 (2026)

A. Every registrant under the Controlled Substances Act manufacturing, distributing
or dispensing a controlled substance shall maintain, on a current basis, a complete and
accurate record of each substance manufactured, received, sold or delivered by him in
accordance with regulations of the board.

    Inventories as required in the federal Comprehensive Drug Abuse Prevention and
Control Act of 1970 shall be deemed in compliance with inventory requirements under
this section.
   B. Records for drugs under Schedules I and II shall be kept separate from other
records. Prescriptions for all Schedule I and II drugs and narcotic prescriptions for
controlled substances listed in Schedules III, IV and V shall be maintained separately
from other prescription drugs in accordance with regulations of the board.

   C. Records for nonnarcotic controlled substances under Schedules III, IV and V
shall be maintained either separately or in such form that they are readily retrievable
and are marked for ready identification in accordance with regulations of the board.
Prescriptions for nonnarcotic controlled substances shall be maintained either in a
separate prescription file or in such form that they are readily retrievable from other
prescription records and are marked for ready identification in accordance with
regulations of the board.

   D. Records shall be maintained for a period of at least three years from the date of
the record and may be inspected as required by authorized agents of the board.

   E. A practitioner is not required to keep records of controlled substances listed in
Schedules II through V that he prescribes or administers in the lawful course of his
professional practice. He shall keep records of controlled substances that he dispenses
other than by prescribing or administering.

   F. Each pharmacy licensed in the state shall provide information relating to the
dispensing of any controlled substance designated by the board. The board shall
administer the collection and dissemination of the information obtained. The manner of
reporting and the extent of the required information shall be designated by regulation of
the board.

History: 1953 Comp., § 54-11-16, enacted by Laws 1972, ch. 84, § 16; 1994, ch. 42, §
2.

                                     ANNOTATIONS

Cross references. — For definitions applicable to Medical Practice Act, see 61-6-6
NMSA 1978.

For definitions applicable to Physician Assistants Act, see 61-6-7.1 NMSA 1978.

For pharmacist clinician prescriptive authority, see 61-11B-3 NMSA 1978.

For the Comprehensive Drug Abuse Prevention and Control Act of 1970, see 21 U.S.C.
§ 801 et seq.

The 1994 amendment, effective May 18, 1994, substituted "that" for "which" in both
sentences in Subsection E and added Subsection F.